Information Journal Paper
APA:
Copy. (2017). Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA. BMC CANCER, 17(1), 0-0. SID. https://sid.ir/paper/718560/en
Vancouver:
Copy. Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA. BMC CANCER[Internet]. 2017;17(1):0-0. Available from: https://sid.ir/paper/718560/en
IEEE:
Copy, “Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA,” BMC CANCER, vol. 17, no. 1, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/718560/en